BCWorld Pharm Co. Ltd. - Product Pipeline Review - 2016

Choose Licence

 

BCWorld Pharm Co. Ltd. - Product Pipeline Review - 2016 Summary Global Markets Directs, BCWorld Pharm Co. Ltd. - Product Pipeline Review, 2016?, provides an overview of the BCWorld Pharm Co. Ltd.s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by BCWorld Pharm Co. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of BCWorld Pharm Co. Ltd. - The report provides overview of BCWorld Pharm Co. Ltd. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses BCWorld Pharm Co. Ltd.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features BCWorld Pharm Co. Ltd.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy - Evaluate BCWorld Pharm Co. Ltd.s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for BCWorld Pharm Co. Ltd. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding BCWorld Pharm Co. Ltd.s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 

Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 BCWorld Pharm Co. Ltd. Snapshot 5 BCWorld Pharm Co. Ltd. Overview 5 Key Information 5 Key Facts 5 BCWorld Pharm Co. Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 BCWorld Pharm Co. Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 BCWorld Pharm Co. Ltd. - Pipeline Products Glance 10 BCWorld Pharm Co. Ltd. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 BCWorld Pharm Co. Ltd. - Early Stage Pipeline Products 11 IND/CTA Filed Products/Combination Treatment Modalities 11 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 BCWorld Pharm Co. Ltd. - Drug Profiles 14 BCWPA-001 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 BCWPC-001 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 risperidone SR 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 BCWPD-003 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 BCWPD-004 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 BCWPP-001 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 BCWPD-001 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 BCWPD-006 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 BCWPD-011 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 BCWPE-003 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 BCWPE-004 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 BCWPY-001 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 BCWPY-002 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 BCWorld Pharm Co. Ltd. - Pipeline Analysis 27 BCWorld Pharm Co. Ltd. - Pipeline Products by Target 27 BCWorld Pharm Co. Ltd. - Pipeline Products by Route of Administration 28 BCWorld Pharm Co. Ltd. - Pipeline Products by Molecule Type 29 BCWorld Pharm Co. Ltd. - Pipeline Products by Mechanism of Action 30 BCWorld Pharm Co. Ltd. - Locations And Subsidiaries 31 Head Office 31 Other Locations & Subsidiaries 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 32 Disclaimer 33

List of Tables BCWorld Pharm Co. Ltd., Key Information 5 BCWorld Pharm Co. Ltd., Key Facts 5 BCWorld Pharm Co. Ltd. - Pipeline by Indication, 2016 7 BCWorld Pharm Co. Ltd. - Pipeline by Stage of Development, 2016 8 BCWorld Pharm Co. Ltd. - Monotherapy Products in Pipeline, 2016 9 BCWorld Pharm Co. Ltd. - Phase I, 2016 10 BCWorld Pharm Co. Ltd. - IND/CTA Filed, 2016 11 BCWorld Pharm Co. Ltd. - Preclinical, 2016 12 BCWorld Pharm Co. Ltd. - Discovery, 2016 13 BCWorld Pharm Co. Ltd. - Pipeline by Target, 2016 27 BCWorld Pharm Co. Ltd. - Pipeline by Route of Administration, 2016 28 BCWorld Pharm Co. Ltd. - Pipeline by Molecule Type, 2016 29 BCWorld Pharm Co. Ltd. - Pipeline Products by Mechanism of Action, 2016 30 BCWorld Pharm Co. Ltd., Other Locations 31


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Markets Direct

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017

Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017 Summary Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are developed by companies and remaining b...

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017 Summary According to the recently published report 'Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017'; Transthyretin (ATTR or Prealbumin or TBP...

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2017 Summary Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Complement component 5 is a protein...

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2017 Summary Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) pipeline Target constitutes close to 7 molecules. Out of which approximat...

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary According to the re...

New Pharmaceuticals and Healthcare Reports